PolyMedix, Inc.(fka PYMXQ)

[ziploc_1]

At this time, the only alternative to bankruptcy is to sell 50% of the company for $10 million with a reshaping of the management team including management compensation and also redoing warrants and options. This would enable continuing studies of 30063 while they search for a partner for phase 3 studies or a potential buy out.